Home
News
Latest News
People Moves
Business Briefs
Newsletters
Features
Features
Reprints
Surveys
Editorial Calendar
Web Exclusives
Issue Archive
Events
MM&M Awards 2012
txt4pharma
MM&M Virtual Summit
Webcasts
Leadership Exchanges
Whitepapers
Directories
Creative Portfolio
Mobile Guide
Interactive Guide
Pharmaceutical Marketers Directory
MM&M Service Directory
Agency Gallery
Direct Marketing Showcase
Medical Education Review
Sales Force Listings
Jobs
About Us
Subscriber Services
Contact Us
Media Information
Editorial Advisory Board
Drug Info
New Drug Dossier
Drug Database
Subscribe
Order Now
Subscriber Services
Newsletters
RSS
|
Login
|
Register
Features Articles
Pharma Report 2012: Get Back in Shape
Marc Iskowitz
May 01, 2012
When big pharma looks in the mirror, what does it see? A body beset by old, expiring brands and not enough energetic, youthful ones to replace them. Marc Iskowitz has industry's regimen for regaining form
Med Ed Report: Show Me the Money
Fred Kinch May 01, 2012
Following industry's CME cutback, dinner meetings and other kinds of peer-to-peer interaction are grabbing more of its meeting spend. How much more, and is this good for medical education? David Rear reports
Product Communications: When Love Is Blind
Fred Kinch May 01, 2012
Getting too enamored of products can lead to losing sight of customer needs. Fred Kinch on how to avoid being blinded by product devotion
MM&M Awards: Dream Team 2012
James Chase
May 01, 2012
This year's judges for the MM&M Awards once again represent the cream of the industry's leaders and thinkers. But this year, there are twice as many of them. Find out who made it onto the panel
Headliner: Hayes' open-door policy opens doors
James Chase
May 01, 2012
Tim Hayes, President, Bayer HealthCare Consumer Care North America
DTC: Beyond the Blockbuster
Matthew Arnold
April 01, 2012
The mass-market, TV-and-print DTC formula is going the way of the vanishing primary care blockbusters it was designed to boost as new media and niche products fill the breach, Matthew Arnold reports
MM&M Therapeutic Focus: Metabolic
Noah Pines April 01, 2012
With the FDA weighing a new Rx diet therapy, we review the anti-obesity sector. Noah Pines on the hype and hurdles for Vivus's Qnexa and its would-be competitors, and the diabetes controversy
Orphan Drugs: Small is the New Big
Deborah Weinstein
April 01, 2012
Orphan drug approvals are up, thanks to marketing exclusivity and development incentives. Deborah Weinstein charts the industry's drive to think small, highlighting tactics for drawing attention
Journal Ad Review 2011: On a Tear
Marc Iskowitz
April 01, 2012
Medical/surgical journal advertising grew in 2011, the second consecutive year it's been in the black. Marc Iskowitz on which categories and brands attracted the most advertising dollars
Headliner: Easing NEJM into its third century
Tanya Lewis April 01, 2012
Tom Easley, publisher, managing director of The New England Journal of Medicine
« Previous
Next »
Video Exclusive
Web Exclusives
Five industry experts advise specialty pharma company on digital strategy
April 20, 2012
Specialty pharma company POZEN assembled a crack team of experts to help shape its digital strategy. Not only did POZEN share with us the text from their contributions, but you can watch exclusive video clips of their valuable perspectives right here.
MM&M Awards 2011 HIghlights
The Best MM&M Awards Ever!
MAHF Ceremony 2012
Photos from the Medical Advertising Hall of Fame Awards ceremony
Most Popular
Most Emailed
Most Recent
Humira on solid ground, analysts say, despite vote on Pfizer hopeful
Sales forces shrank in 2011, but not everywhere
Goodbye Plavix, hello competition
Wolters Kluwer deals health analytics unit to private equity firm
Makers of pain pills, advocacy groups at center of Senate probe
Saatchi shop rebrands to sharpen specialty focus
RX-to-OTC proposal gets mixed reviews
Roche ends dalcetrapib trial, questions linger on CETP class
Docs trust ED drugs above all, go with their emotions when prescribing
Nurses get their own app with Lippincott launch
Harvard urges faculty to ditch journals
Massachusetts gift ban under attack (again)
Enbrel reps risk layoff, as Pfizer calls early end to US selling
Pharma Report 2012: Get Back in Shape
Novo Nordisk plans US hiring spree as Q1 sales jump 10%
Pfizer, Crestor tops for global promotional spend in 2011
Wolters Kluwer deals health analytics unit to private equity firm
Humira on solid ground, analysts say, despite vote on Pfizer hopeful
Med Ed Report: Show Me the Money
Bydureon catching on among endos but low profits expected, Amylin says
Pharmas are from Mars, Payers are from Venus
Goodbye Plavix, hello competition
Indian conglomerate buys Manhattan Research parent for $635m
Sales forces shrank in 2011, but not everywhere
National plan seeks Alzheimer's treatment by 2025
Coach vs. cancer in BMS-backed awareness effort
Wolters Kluwer deals health analytics unit to private equity firm
RX-to-OTC proposal gets mixed reviews
Siding with Lilly, appeals court overturns decision in rep overtime case
Humira on solid ground, analysts say, despite vote on Pfizer hopeful
Popular Topics
Acquisition
Adherence
Agency
App
Conflict Of Interest
Digital
Direct To Consumer (DTC)
Downsize
Education & Awareness
FDA
Health Plans
HMOs
Hospitals
Insurers
Law
Marketing Research
Mobile
Obesity
Oncology
Payers
PBMs
Physicians
Rebranding
REMS
Sales Force